We have previously demonstrated that the expression of the soluble extracellular domain of the transmembrane ligand for Notch receptors, Jagged 1 (sJ1), in NIH 3T3 cells results in the formation of a matrix-dependent chord-like phenotype, the loss of contact inhibition of growth, and an inhibition of pro-␣1(I) collagen expression. In an effort to define the mechanism by which sJ1 induces this phenotype, we report that sJ1 transfectants display biochemical and cytoskeletal alterations consistent with the activation of Src. Indeed, cotransfection of sJ1 transfectants with a dominant-negative mutant of Src resulted in the loss of matrix-dependent chord formation and correlated with the restoration of type I collagen expression and contact inhibition of growth. We also report that the sJ1-mediated induction of Src activity and related phenotypes, including chord formation, may result from the inhibition of endogenous Jagged 1-mediated Notch signaling since it was not possible to detect an sJ1-dependent induction of CSL-dependent transcription in these cells. Interestingly, NIH 3T3 cells transfected with dominant-negative (but not constitutively active) mutants of either Notch 1 or Notch 2 displayed a similar Src-related phenotype as the sJ1 transfectants. These data suggest that the ability of sJ1 to mediate chord formation is Src-dependent and requires the repression of endogenous Jagged 1-mediated Notch signaling, which is tolerant to the destabilization of the actin cytoskeleton, a mediator of cell migration.
Notch receptors are transmembrane polypeptides that regulate cell fate determination and whose activities are critical for a wide variety of developmental and physiological processes (1, 2) . Notch genes have been found in all invertebrate and vertebrate species examined to date, with four Notch genes (Notch 1-4) expressed in mice, rats, and humans (3) (4) (5) (6) . Notch ligands are also evolutionarily conserved transmembrane polypeptides that are divided into Delta-like or Serrate-like subclasses based on the absence or presence, respectively, of an extracellular cysteine-rich region located N-terminal to the transmembrane domain (7) . Four Delta-like (Delta 1-4) and two Serrate-like (Jagged 1 and 2) genes have thus far been identified in vertebrates (8 -10) . Notch ligands were previously thought to function exclusively as membrane-bound polypeptides that interact directly with Notch through cell-cell contact (1, 2) . However, biochemical evidence has shown that Kuzbanian, an ADAM (a disintegrin and metalloprotease domain) family extracellular metalloprotease genetically linked to the Drosophila Notch null neurogenic phenotype, cleaves the Drosophila Notch ligand Delta near the transmembrane domain, potentially turning Delta into a soluble ligand (11) . No proteases that cleave Serrate/Jagged ligands have been identified thus far, although mRNA representing human Jagged 1 lacking the transmembrane and intracellular domains has been detected in human endothelial cells (12) and genetic screens (13) and likely represents a soluble form of the ligand. To date, it is still unclear as to whether the soluble forms of the human Notch ligands inhibit or activate Notch signaling pathways (14 -19) .
We have previously reported that mRNA representing both the full-length and soluble, non-transmembrane forms of the Notch ligand Jagged 1 was up-regulated in human endothelial cells during the fibrin-mediated pathway of in vitro angiogenesis (12) . Indeed, Jagged 1 expression is mandatory for normal blood vessel formation since embryonic mice are not viable beyond stage embryonic day 10.5 in a Jagged 1 null situation, presumably as a result of massive hemorrhage associated with malformation of the vasculature (20) . During studies to define the role of Jagged 1 signaling in angiogenesis, we noted prominent phenotypic alterations in cells stably transfected with a naturally occurring and secreted form of Jagged 1 lacking the transmembrane and intracellular domains (21) . Indeed, stable soluble Jagged 1 (sJ1) 1 NIH 3T3 cell transfectants exhibit a wide range of biochemical, morphological, and behavioral changes that include loss of pro-␣1(I) collagen expression, decreased sensitivity to contact inhibition, and the matrix-dependent formation of chord-like structures (21) , a morphologic characteristic reminiscent of the early-to-mid stage phenotype exhibited during the pathway of human endothelial cell differentiation (22) . The role of Jagged 1 as an angiogenic factor was further substantiated by the observation that the implantation of lethally irradiated sJ1 NIH 3T3 cell transfectants in the conventional chorioallantoic membrane assay induced the growth of neovessels (21) .
In an effort to elucidate the signaling mechanisms responsible for the sJ1-inducible chord-like phenotype, we examined the role of protein tyrosine phosphorylation in this system. We report that sJ1 NIH 3T3 cell transfectants demonstrate a pattern of protein tyrosine phosphorylation indicative of an increase in the activity of Src, and the expression of a dominantnegative form of Src in the sJ1 NIH 3T3 cell transfectants was able to revert matrix-dependent chord formation, including a down-regulation of F-actin stress fibers, an observation consistent with the activation of Src (23) . In addition, treatment with amlexanox, an agent known to repress cell migration and attenuate the F-actin cytoskeleton (24) , was unable to repress chord-formation, suggesting that cell migration is not requisite for chord formation in vitro. Furthermore, we found that the Src-dependent phenotype exhibited by sJ1 NIH 3T3 cell transfectants most likely results from inhibition of endogenous Jagged 1-mediated Notch signaling, as NIH 3T3 cells expressing the dominant-negative extracellular and soluble portions (but not the intracellular and constitutively active mutants) of Notch 1 and Notch 2 exhibit phenotypic changes similar to those observed in sJ1 transfectants.
EXPERIMENTAL PROCEDURES

Generation of Expression Constructs and Stable NIH 3T3
Transfectants-Insert-less pMEXneo and sJ1 constructs and stable NIH transfectants were obtained as previously described (21) . The Jagged 1 construct was obtained by cloning the complete coding region from a cDNA clone previously isolated in our laboratory (12) into the pcDNA3.1 ϩ neomycin-resistant vector (Invitrogen) using the BamHI and XhoI restriction sites to produce the plasmid pFLJ1G418. The constitutively active and dominant-negative Notch 1 (caN1 and dnN1, respectively) constructs tagged with a V5/His epitope were obtained by first modifying the stop codon of the cDNA encoding human Notch 1 (a generous gift of T. Kadesch, University of Pennsylvania) to an EcoRI site by site-directed mutagenesis using the QuickChange site-directed mutagenesis kit (Stratagene) following the manufacturer's instructions. The entire Notch 1 coding region was then cloned into the pcDNA4.0V5/His version a vector (Invitrogen) to produce the plasmid pFLN1V5/His. The caN1 construct was obtained by inserting an EcoRI site into the coding region of this tagged, full-length Notch 1 construct immediately upstream of the first Met residue (amino acid 1807) in the cytoplasmic domain of the Notch 1 polypeptide (GenBank TM /EBI accession number M73980). The cDNA encoding the entire cytoplasmic domain minus the stop codon of pFLN1V5/His was then excised with the restriction enzymes EcoRI and EcoRV and cloned into the EcoRI and NheI sites of the pcDNA4.0V5/His version a vector to produce the caN1 construct with a V5/His tag (pCAN1V5). The dnN1 construct was also obtained using site-directed mutagenesis to produce another EcoRI site immediately upstream of the transmembrane domain (amino acids 1528) in pFLN1V5/His. The cDNA representing Notch 1 (amino acids 1-1528) was then cloned into the pcDNA4.0V5/His version a vector using the EcoRI site to produce the dnN1 construct with a V5/His tag (pDNN1V5/His). The V5/His-tagged constitutively active Notch 2 (caN2) construct was obtained using site-directed mutagenesis to change the stop codon in a plasmid encoding the cytoplasmic domain of human Notch 2 (phN2IC, a generous gift from S. Artavanis-Tsakonas, Harvard University) to an EcoRI site, and the cDNA representing the entire cytoplasmic domain was then cloned into the BamHI and EcoRI restriction sites of the pcDNA4.0V5/His version b vector to produce the plasmid pCAN2V5/His. The dnN2 construct was obtained by introducing an XhoI site into the coding region of phN2-complete (a generous gift from S. Artavanis-Tsakonas) immediately upstream of the transmembrane domain and excised with EcoRI and XhoI to release a fragment representing the extracellular domain (amino acids 1-1676; sequence map obtained from S. Artavanis-Tsakonas). This fragment was then cloned into the EcoRI and XhoI sites of the pcDNA4.0V5/His version b vector to produce pDNN2V5/His. Stable NIH 3T3 transfectants expressing full-length Jagged 1 (flJ1), caN1, caN2, dnN1, and dnN2 were generated as previously described (25) . Clonal transfectants were selected using the appropriate antibiotic (G418 (1 mg/ml) for flJ1 and Zeocin (150 g/ml) for the Notch mutants) using standard methods previously described (25) . Clonal transfectants were screened for expression using antibodies against the C terminus of Jagged 1 (Santa Cruz Biotechnology) for flJ1 transfectants or against the V5/His epitope (Invitrogen) for the Notch mutants. At least two positive clones for each line were initially typed for phenotype. Clones flJ1-5, caN1-A, caN2-L, dnN1-7, and dnN2-2 were used for the experiments presented in this report. For the generation of the dominant-negative Src-sJ1 cotransfectants, the sJ1 NIH 3T3 cell transfectants (clone 38.1) were cotransfected with a dominant-negative mutant of Xenopus laevis Src in which lysine 294 was replaced by alanine and tyrosine 526 by phenylalanine. The dominant-negative Src mutant was cloned into the pcDNA3.1 ϩ hygromycin vector (Invitrogen) using XhoI and XbaI restriction sites, and the selection of stable transfectants was performed as previously described (25) . Control transfection was performed using the insert-less pcDNA3.1 ϩ hygromycin vector. The expression of the dominant-negative Src construct was confirmed by reverse transcription-polymerase chain reaction analysis using two Src primers: the forward primer encompassing nucleotides 72-90 of the X. laevis Src cDNA was X. laevis Src-specific, and the reverse primer corresponding to nucleotides 453-470 was common for both X. laevis and murine Src. The reverse transcription-polymerase chain reaction results were confirmed by immunoblot analysis of cell lysates with anti-Src2 antibodies (Santa Cruz Biotechnology). Clone dn3 representing the dominant-negative Src-sJ1 NIH 3T3 cell cotransfectants was used for these studies.
Cell Culture and Immunoblot Analysis-The stable NIH 3T3 transfectants were grown in Dulbecco's modified Eagle's medium (Life Technologies, Inc.) supplemented with 10% (v/v) bovine calf serum (Hyclone Laboratories), 100 units/ml penicillin G, 100 g/ml streptomycin, 0.25 g/ml Fungizone (Life Technologies, Inc.), and the appropriate antibiotic as determined by the resistance of the expression construct. Cells were made quiescent by incubating the confluent monolayer in Dulbecco's modified Eagle's medium containing 0.25% (v/v) bovine calf serum for 24 h and further stimulated for an additional 24 h by the addition of 10 g/ml heparin (The Upjohn Co.) and 10 ng/ml recombinant human FGF-1, prepared as previously described (26) . Immunoprecipitation of cortactin was performed as described (27) , and immunoblot analysis of total phosphotyrosine, total Src, and phosphotyrosine-specific Src (Tyr(P) 418 ) was carried out using antibodies from Upstate Biotechnology, Inc., Santa Cruz Biotechnology, and BioSource, International, respectively, following methods previously described (27) . Pro-␣1(I) collagen (monoclonal antibody SP1.D8 from the Developmental Studies Hybridoma Bank, University of Iowa) and cortactin (28) immunoblot analyses used similar methods. Amlexanox (AAl673, Takeda Chemical Industries, Osaka, Japan) was dissolved in equimolar NaOH as described (29) , and the Src inhibitors PP2 (Calbiochem) and PD0180970 (Parke-Davis) were dissolved in dimethyl sulfoxide.
Fluorescence Microscopy, Chord Formation, and Cell Migration and Growth-Fluorescence staining was performed as previously described (27) . Briefly, cells were plated on glass coverslips. After 24 h, the cells were fixed with 4% (v/v) paraformaldehyde in PBS for 5 min at 25°C, and the monolayers were washed with PBS and blocked with PBS containing 5% (w/v) bovine serum albumin, 0.1% (v/v) Triton X-100, 0.1% (v/v) Tween 20, and 0.1% (w/v) NaN 3 (blocking buffer) for 1 h. For F-actin staining, the NaN 3 monolayer was washed with PBS three times, incubated for 20 min with 0.1 g/ml rhodamine-conjugated phalloidin (Sigma), washed three times with PBS, and embedded in 50% (v/v) glycerol containing 0.1% (w/v) phenylenediamine. Cells were studied using a Leica TCS-SP fluorescent confocal microscope, and pictures of optical sections most abundant in fluorescent F-actin were recorded. To study substrate-dependent chord formation, cells were plated on cell culture dishes with and without type I collagen. Collagen gels were formed in six-well cell culture dishes by mixing type I collagen (Becton Dickinson), 10ϫ PBS, 1 N NaOH, and sterile distilled water at a 2.5:1: 0.06:6.5 (v/v) ratio on ice and then quickly dispensing (1.5 ml) into the individual wells. The collagen mixture was allowed to gel for 1 h prior to use. For studies involving cell migration, confluent monolayers were scraped, and the response to injury was recorded by phase-contrast microscopy as previously described (27) . Cell growth was examined by plating cells in complete cell culture medium on fibronectin-coated dishes (10 g/cm 2 ) at an initial density of 2 ϫ 10 4 (see Fig. 4B ) or 4 ϫ 10 4 (see Fig. 2C ) cells/well. Cell numbers were monitored every 2 days by trypsin/EDTA cell detachment and quantitation using a hemocytometer as described (21) .
Transient Transfection Assays of CSL-regulated Transcription-All cells used in this assay were plated onto fibronectin-coated 12-well tissue culture dishes and transiently transfected at 70% confluency with the specific constructs indicated using Fugene 6 (Roche Molecular Biochemicals) following the manufacturer's instructions. For the CBF1 reporter assay, NIH 3T3 cells were transiently transfected with 500 ng of a luciferase construct driven by four tandem copies of the CBF1 response element (30) and 500 ng of the insert-less pMEXneo vector or the flJ1, sJ1, caN1, dnN1, caN2, or dnN2 construct. All cells were also transfected with 100 ng of the Renilla SV40 construct (Promega) as an internal control for transfection efficiency. The medium was replaced with fresh Dulbecco's modified Eagle's medium supplemented with 10% (v/v) bovine calf serum 24 h after transfection. The cells were harvested 24 h after the media change, and luciferase/Renilla activity was measured using the Promega dual-luciferase reporter assay system. The efficiency of transcription was measured and normalized in relationship to the activity of pRL-Renilla SV40, and activity was reported as the ratio of luciferase to Renilla activity. Error bars represent S.E. All samples were performed in triplicate for each experiment, and the experiments were performed a minimum of three times. For the HES1 reporter assay, insert-less pMEXneo, flJ1, sJ1, caN1, dnN1, caN2, and dnN2 stable NIH 3T3 cell transfectants were transiently transfected with 500 ng of a CAT reporter driven by the region of the HES1 promoter encompassing nucleotides Ϫ194 to ϩ160 (31) and 500 ng of the caN1 construct. Cells were also transfected with 100 ng of the cytomegalovirus-luciferase construct (pGL3-Control, Promega) as an internal control for transfection efficiency. The medium was replaced with fresh Dulbecco's modified Eagle's medium supplemented with 10% (v/v) bovine calf serum 24 h after transfection. The cells were harvested 24 h after the media change, and CAT and luciferase activities were measured using the Promega CAT reporter enzyme assay system and luciferase assay kit, respectively. Activity was reported as the ratio of CAT to luciferase activity. Error bars represent S.E. All samples were performed in triplicate for each experiment, and the experiments were performed a minimum of three times.
RESULTS
Expression of Soluble Jagged 1 Mediates the Tyrosine Phosphorylation of Cortactin and an Attenuation of F-actin Stress Fibers in Vitro-
In an attempt to elucidate the potential role of tyrosine kinases as possible mediators of sJ1-dependent function, the protein tyrosine phosphorylation profiles of whole cell lysates obtained from insert-less pMEXneo and sJ1 NIH 3T3 cell transfectants were examined by anti-phosphotyrosine immunoblot analysis. As shown in Fig. 1A , the steady-state levels of phosphotyrosine-containing proteins were significantly different between the insert-less vector and sJ1 NIH 3T3 cell transfectants. Interestingly, we observed the presence of two prominent phosphotyrosine-containing polypeptides with apparent molecular masses of ϳ60 and 80 kDa in the sJ1 NIH 3T3 cell transfectants (Fig. 1A) . Immunoblot analysis of these lysates using an anti-Src phosphotyrosine-specific antibody (Src pY 418 ) enabled us to determine that the 60-kDa polypeptide represented the phosphotyrosine signature of activated Src (Fig. 1A, lower panel) . Likewise, cortactin immunoprecipitation followed by phosphotyrosine and cortactin immunoblot analysis (Fig. 1B) enabled us to determine that the 80-kDa polypeptide represented the tyrosine phosphorylation state of the Src substrate-and F-actin-binding protein cortactin (29) . In addition, although the intracellular levels of cortactin did not vary significantly in response to either FGF-1, a known inducer of Src-dependent cortactin phosphorylation (29) , or PP2, a Srcspecific tyrosine kinase inhibitor (32), we observed an increase in the tyrosine phosphorylation of cortactin in quiescent sJ1 NIH 3T3 cell transfectants, which was further exaggerated by FGF-1 stimulation and repressed by the addition of PP2 (Fig.  1B) . These results suggest that the tyrosine phosphorylation of cortactin is enhanced in the sJ1 NIH 3T3 cell transfectants.
To determine whether the tyrosine phosphorylation of cortactin in the sJ1 NIH 3T3 cell transfectants was functional, we examined these cells for the presence of F-actin stress fibers. As shown in Fig. 1C (panel b) , fluorescent confocal microscopy of the sJ1 NIH 3T3 cell transfectants stained with a fluorescent rhodamine conjugate of phalloidin exhibited a prominent reduction of F-actin fibers compared with insert-less vector control cells (panel a). This observation is consistent with the activity of Src-induced tyrosine phosphorylation of cortactin (32), leading to detachment of cortactin from actin microfilaments (33) and dissociation of stress fibers from individual filaments.
Cotransfection of a Dominant-negative Src Construct Represses the Formation of the Soluble Jagged 1-mediated Chordlike Phenotype-In an attempt to determine whether some or all of the phenotypic characteristics of the sJ1 NIH 3T3 cell transfectants (21) are associated with an increase in Src activity, we cotransfected the sJ1 NIH 3T3 cell transfectants with a dominant-negative mutant of X. laevis Src containing two point mutations, one of which inactivates the catalytic domain and the other which maintains Src in an activated conformation. Interestingly, the dominant-negative Src-sJ1 NIH 3T3 cell cotransfectants displayed a dramatic decrease in the phosphorylation of cortactin (data not shown) (24) , enhanced cell spreading on plastic (data not shown), an increase in the level of F-actin stress fibers (Fig. 1C, panel c) , and a repression of the chord-like phenotype in response to type I collagen ( Fig. 2A,  panel c) . Likewise, the addition of PD0180970, a novel and highly specific inhibitor of Src, was also able to repress chord formation in the sJ1 NIH 3T3 cell transfectants (data not shown). The expression of dominant-negative Src in the sJ1 NIH cell transfectants also reverted the expression of pro-␣1(I) collagen (Fig. 2B) and restored contact inhibition of cell growth (Fig. 2C) . In contrast, cotransfection of the sJ1 NIH 3T3 cell transfectants with an insert-less vector did not alter any of the phenotypic characteristics displayed by sJ1 NIH 3T3 cell transfectants (data not shown). These data suggest that several sJ1-mediated characteristics, including chord formation, may be attributed to the function of Src. In addition, these data also imply a role for Src in the regulation of Notch-dependent signaling events.
The Chord-like Phenotype Exhibited by Soluble Jagged 1 NIH 3T3 Cell Transfectants Is Resistant to an Attenuation of the Actin Cytoskeleton and Cell Migration-Because sJ1 expression attenuates the appearance of F-actin stress fibers in NIH 3T3 cells, we questioned whether chord formation could be stimulated by the down-regulation of the F-actin cytoskeleton.
To examine this premise, we treated insert-less pMEXneo and sJ1 NIH 3T3 cell transfectants with amlexanox, an agent that down-regulates the abundance of F-actin stress fibers without destroying F-actin filaments (24) . Although amlexanox was able to abolish the presence of the majority of actin stress fibers in NIH 3T3 cells (24) and insert-less vector control transfectants (Fig. 1C, panel d) , amlexanox failed to induce chord formation on a type I collagen extracellular matrix by insertless pMEXneo NIH 3T3 cell transfectants (Fig. 2D, panel c) .
Thus, it appears that the attenuation of actin stress fibers is not in itself sufficient to induce substrate-dependent chord formation. Interestingly, however, amlexanox was not able to repress the formation of the type I collagen-dependent chord- FIG. 2 . A, the expression of dominant-negative Src abrogates substrate-dependent chord formation by sJ1 NIH 3T3 transfectants. Insert-less pMEXneo (panel a), sJ1 (panel b) and dominant-negative Src-sJ1 (panel c) NIH 3T3 cell transfectants were plated on type I collagen prepared as described under "Experimental Procedures" and examined 24 h after incubation by phase-contrast microscopy (magnification ϫ 20). B, the cotransfection of dominant-negative Src restores the expression of pro-␣1(I) collagen in sJ1 NIH 3T3 cell transfectants. The lysates from insert-less pMEXneo, sJ1 (clones 38.1 and 38.4), and dominant-negative Src-sJ1 (dnSrc:sJ1) NIH 3T3 cell transfectants were prepared and immunoblotted for pro-␣1(I) collagen as described under "Experimental Procedures." C, the expression of dominant-negative Src decreases the saturation density of sJ1 NIH 3T3 cell transfectant growth. The growth dynamics of insert-less pMEXneo, sJ1, and dominant-negative Src-sJ1 NIH 3T3 cell transfectants were determined as described under "Experimental Procedures." Data are reported as viable cell number as a function of time, and 4 ϫ 10 4 cells were seeded per dish. Error bars represent S.E. D, amlexanox does not suppress the type I collagen-dependent chord formation by sJ1 NIH 3T3 cell transfectants. Insert-less vector pMEXneo (panels a and c) and sJ1 (panels b and d) NIH 3T3 cell transfectants were plated in the presence (panels c and d) and absence (panels a and b) of 0.3 mM amlexanox on type I collagen prepared as described under "Experimental Procedures" and examined after 24 h of incubation by phase-contrast microscopy (magnification ϫ 20). E, the expression of dominant-negative Src in sJ1 NIH 3T3 cell transfectants does not alter their impaired migratory ability. Insert-less pMEXneo, sJ1, and dominant-negative Src-sJ1 NIH 3T3 cell transfectants were analyzed using the response-to-injury model of cell migration as described (27) . Phase-contrast photomicrographs (magnification ϫ 10) are shown at the times indicated.
like phenotype exhibited by the sJ1 NIH 3T3 cell transfectants (Fig. 2D, panel d) . In addition, whereas the dominant-negative Src-sJ1 NIH 3T3 cell cotransfectants displayed an increased resistance to amlexanox-induced destabilization of the F-actin cytoskeleton (Fig. 1C, panel f) , these cells did not exhibit a type I collagen-dependent chord-like phenotype in the presence of amlexanox (data not shown).
Because the disappearance of actin stress fibers can impair the migratory activity of the cells (35) and amlexanox is a potent inhibitor of cell migration (24), we examined the migratory phenotype of the sJ1 NIH 3T3 cell transfectants. As shown in Fig. 2E , sJ1 NIH 3T3 cell transfectants exhibited a decrease in migration compared with insert-less vector NIH 3T3 cell control transfectants; however, the expression of dominantnegative Src did not restore the migratory phenotype, suggesting that another signaling pathway, other than Src, may be involved in the sJ1-dependent repression of cellular motility in these cells.
The Src-dependent Phenotypic Characteristics Displayed by Soluble Jagged 1 Transfectants May Result from Inhibition of Endogenous Jagged 1-mediated Notch
Signaling-The signaling pathways initiated by sJ1 that lead to phenotypic changes in the NIH 3T3 cell are unknown, but are likely to involve interactions of the soluble ligand with Notch 1 and/or Notch 2 receptors since transcripts for these (but not Notch 3 and Notch 4) are expressed in NIH 3T3 cells (data not shown). Extensive genetic and biochemical studies in both invertebrates and vertebrates have demonstrated that activated Notch mediates many of its effects by up-regulating the expression of the HES (hairy enhancer of split) family of transcription factors after forming a complex with CSL (CBF1/RBP-Jk/KBF2 in mammals, Su(H) in Drosophila and X. laevis, and LAG-2 in Caenorhabditis elegans) proteins (31, 35, 36) . Therefore, in an attempt to determine if the phenotype exhibited by sJ1 NIH 3T3 cell transfectants, including chord formation, results from an increase in Notch activity, we assayed insert-less vector control and sJ1 NIH 3T3 transfectants using standard Notch reporter assays (30, 31) that measure the activation of the traditional CSL/HES-dependent Notch signaling pathway. As anticipated, NIH 3T3 cells transfected with flJ1, caN1, and caN2 displayed an increase in CSL-mediated transcription of the luciferase reporter gene as compared with insert-less vector control transfectants. In contrast, NIH 3T3 cells transfected with sJ1 displayed a decrease in the activity of the CSL-luciferase reporter similar to that observed with the dnN1-and dnN2-transfected NIH 3T3 cells (Fig. 3A) . Interestingly, caN1-mediated transcriptional activation of a CAT reporter linked to the HES1 promoter containing the CSL/Notch response element was partially inhibited in the sJ1, dnN1, and dnN2 stable transfectants (Fig. 3B) . These data suggest that the sJ1-dependent phenotype, including chord formation, may not be the result of CSL/Notch signaling since sJ1, like dnN1 and dnN2, appears to repress endogenous CSL-mediated transcriptional activity in the NIH 3T3 cell.
As activated Notch has also been reported to signal through a CSL-independent pathway (37, 38), we could not conclude solely based on the CSL reporter assay that the Src-dependent sJ1 phenotype resulted from an inhibition of endogenous Jagged 1-mediated Notch signaling. Therefore, to address this issue, we utilized a genetic approach in which we examined the phenotype of NIH 3T3 cells stably transfected with either constitutively active or dominant-negative mutants of Notch 1 and Notch 2. We reasoned that if sJ1 was agonizing Notch signaling pathways by activating endogenous Notch 1 and/or Notch 2 receptors, then NIH cells stably expressing constitutively active mutants of these Notch receptors should display some, if not all, of the sJ1 phenotypic characteristics. Likewise, if sJ1 antagonizes endogenous signaling, then the phenotype of stable transfectants expressing dominant-negative mutants of Notch 1 and Notch 2 should instead resemble the phenotype observed in sJ1 stable lines. Thus, we prepared the caN1 and caN2 forms by deletion of the extracellular and transmembrane domains of Notch 1 and Notch 2, and the dnN1 and dnN2 forms by deletion of the transmembrane and intracellular domains of these receptors. These four Notch receptor mutants were individually transfected into NIH 3T3 cells, and the results from our analysis of these stable transfectants are shown in Figs. 4 and 5. Our analysis revealed that in general, the phenotype of both dnN1-and dnN2-expressing stable transfectants was similar to that of sJ1 NIH 3T3 cell transfectants, whereas the caN1 and caN2 NIH 3T3 cell transfectants did not share any characteristics of the sJ1 NIH 3T3 cell transfectants   FIG. 3 . A, the transcriptional activity of the CBF1 response element is altered in sJ1, dnN1, and dnN2 NIH 3T3 cell transfectants. NIH 3T3 cells were transiently transfected with 500 ng of a luciferase construct driven by four tandem copies of the CBF1 response element and 500 ng of insert-less pMEXneo (Vec), flJ1, sJ1, caN1, dnN1, caN2, or dnN2 as indicated. All cells were also transfected with 100 ng of the Renilla SV40 construct as an internal control for transfection efficiency. Transfection and the subsequent determination of the luciferase and Renilla activities were carried out as described under "Experimental Procedures." Activity is shown as the ratio of luciferase to Renilla activity. Error bars represent S.E., and changes were significant as determined by Student's t test. B, the ability of caN1 to stimulate the activity of the HES1 promoter is repressed in sJ1, dnN1, and dnN2 stable transfectants. Insert-less pMEXneo, flJ1, sJ1, caN1, dnN1, caN2, and dnN2 NIH 3T3 cell transfectants were transiently transfected with 500 ng of a CAT reporter driven by the HES1 promoter and 500 ng of the caN1 construct as described under "Experimental Procedures." Cells were also transfected with 100 ng of the cytomegalovirus-luciferase promoter (pGL3-Control) as an internal control for transfection efficiency. CAT and luciferase activities were measured as described under "Experimental Procedures" and are reported as the ratio of CAT to luciferase activity. Error bars represent S.E. and instead resembled insert-less vector control cells. We observed that like the sJ1 transfectants, the dnN1 (but not the caN1) NIH 3T3 cell transfectants displayed an increase in the tyrosine phosphorylation of Src (Figs. 1A and 4A) and cortactin ( Fig. 1B and data not shown) relative to insert-less vector NIH 3T3 cell transfectants. Similar results for Src tyrosine phosphorylation were also observed with the dnN2 and caN2 NIH 3T3 cell transfectants (data not shown). In addition, the dnN1 and dnN2 (but not the caN1 and caN2) NIH 3T3 cell transfectants also displayed Src-dependent sJ1-like phenotypic characteristics, including a decrease in the formation of actin stress fibers (Fig. 4B , compare with pMEXneo and sJ1 in Fig. 1C , panels a and b, respectively) and a decreased sensitivity to contact inhibition (Fig. 4C) . Although not as pronounced as observed in the sJ1 NIH 3T3 transfectants, other Src-dependent characteristics such as a decrease in the expression of pro-␣1(I) collagen (Fig. 4D) and the type I collagen-dependent formation of the chord-like phenotype (Fig. 5A) were also observed in the dnN1 and dnN2 (but not the caN1 and caN2) cell transfectants. Furthermore, the migratory ability of the dnN1 and dnN2 (but not the caN1 and caN2) NIH 3T3 cell transfectants was also impaired (Fig. 5B) in a manner similar to that observed with the sJ1 NIH 3T3 cell transfectants (Fig. 2E) . As anticipated, expression of the dnN1 and dnN2 constructs did not increase CSL-mediated transcription (Fig. 3A) and also repressed the ability of transiently transfected caN1 to stimulate transcription of the HES1 promoter (Fig. 3B) . Thus, we suggest that the inhibition of endogenous Jagged 1-mediated Notch signaling by sJ1 promotes an increase in Src-dependent cellular functions, leading to alterations in the NIH 3T3 phenotype, including the induction of a type I collagen-dependent chord-like phenotype. DISCUSSION Our data suggest that the induction of Src activity may be responsible for the manifestation of many of the phenotypic characteristics observed in the sJ1 NIH 3T3 cell transfectants, including the loss of pro-␣1(I) collagen expression, decreased sensitivity to contact inhibition, and the decrease in actin stress fibers. These results are in agreement with observations independently documented by other groups examining the cellular effects of the ectopic expression of constitutively active mutants of Src. For example, Frankfort and Gelman (39) reported a 10-fold decrease in pro-␣1(I) collagen mRNA expression after transfection of NIH 3T3 cells with v-src that correlated with the Src-induced transcriptional activation of collagenase-1 expression (40), a gene whose expression was also found to be up-regulated in the sJ1 NIH 3T3 cell transfectants (21) . Loss of contact inhibition is also a well documented consequence of the expression of v-src in a variety of cell types (41) and contributes to the oncogenic activity of this gene. In addition, it is also known that the expression of constitutively active v-src results in a dramatic down-regulation of actin stress fibers (42) . Thus, the sJ1-dependent attenuation of stress fibers by Src may result in the inhibition of chaotic lateral cell migration (24, 34) and could promote the stabilization of the chord-like phenotype exhibited by the sJ1 NIH 3T3 cell transfectants. Because the disruption of stress fibers by amlexanox treatment is not by itself sufficient to promote chord formation in response to type I collagen in NIH 3T3 cells, we suggest that the activation of Src in the sJ1 NIH 3T3 cell transfectants may provide other necessary changes in the actin cytoskeleton that are essential for the generation of the chordlike phenotype. In addition, the induction of this phenotypic characteristic may require the function of other cellular proc -FIG. 4. A, the dnN1 ( were stained with rhodamine-phalloidin for the presence of actin stress fibers and analyzed by fluorescent confocal microscopy as described under "Experimental Procedures." C, the saturation density of NIH 3T3 cells is increased by the expression of dnN1 and dnN2 (but not caN1 and caN2). The growth dynamics of insert-less pMEXneo, sJ1, caN1, caN2, dnN1, and dnN2 NIH 3T3 cell transfectants were determined as described under "Experimental Procedures." Data are reported as viable cell number as a function of time, and 2 ϫ 10 4 cells were seeded per dish. Error bars represent S.E. D, the expression of pro-␣1(I) collagen is reduced in dnN1 and dnN2 NIH 3T3 stable transfectants. The lysates of logarithmically growing insert-less pMEXneo, sJ1, flJ1, caN1, caN2, dnN1, and dnN2 NIH 3T3 cell transfectants were prepared and immunoblotted for pro-␣1(I) collagen as described under "Experimental Procedures." esses mediated by sJ1, including the enhancement of specific cell-cell contacts and cell polarization, consistent with the observation that sJ1 is able to alter cell-matrix and cell-cell interactions in NIH 3T3 cells (43) .
Although the mechanism mediated by sJ1 to induce Src activity is not known, phenotypic analysis of NIH 3T3 cells expressing Notch 1 and Notch 2 mutants suggests that the Src-dependent sJ1 phenotype described here and in our previous report (21) may result from sJ1 acting as a decoy ligand for Notch 1 and/or Notch 2 and, as a result, may enable the repression of the traditional CSL-dependent Jagged 1-mediated Notch signaling pathways in the NIH 3T3 cell. Although the addition of a peptide representing only the DSL (for Delta, Serrate, and Lag2) domain of Jagged 1 was shown to activate Notch in hematopoietic precursor cells (44) , other reports provide evidence that supports the role of soluble Notch ligands as antagonists of Notch signaling events. Indeed, the overexpression of genetically engineered, soluble ligands in both Drosophila (15) and Xenopus (16) displays a Notch null phenotype. In addition, the expression of truncated and soluble forms of the human Jagged 1 polypeptide resulting from mutations located within the coding region of the structurally conserved extracellular domain of the gene has been proposed to be the causal agent of the Alagille syndrome developmental disorder (13, 45) . These data suggest that deletions within the extracellular domain of Jagged 1 alter the function of the ligand. Although Shimizu et al. (46, 47) have demonstrated that soluble forms of Jagged 1 and other Notch ligands bind to Notch 1-3 receptors, they utilized exclusively the full-length versions of the ligands and not their soluble forms for their biological assays. Furthermore, Varnum-Finney et al. (48) have recently reported that soluble mutants of the Notch ligand Delta are also capable of activating Notch, but only when they are immobilized onto a surface and mimic full-length ligands. In contrast, soluble forms of Delta act as repressors of CSL-dependent Notch-mediated activity (48) , an observation consistent with our results. Indeed, these observations may explain why the soluble recombinant forms of Jagged 1 and other Notch ligands bind to Notch 1-3 and fail to exhibit Notch-dependent activities (46, 47) . Although it is unclear how the soluble form of Jagged 1 interacts with Notch 1 and Notch 2 on the surface of the NIH 3T3 cell, it is likely that the NIH 3T3 cell may be able to overcome the putative requirements for ligand immobilization and enable the soluble form of Jagged 1 to function as a repressor of its full-length precursor form.
It is also likely that endogenous Jagged 1-mediated Notch signaling influences NIH 3T3 cell homeostasis in vitro and that disruption of traditional CSL-dependent Jagged 1-mediated Notch signaling leads to the induction of differentiation-like behaviors such as changes in gene expression and chord formation (21) . Certainly, the role of Notch as an inhibitor of differentiation is well documented (1, 2) , and the generation of soluble ligands by proteolytic cleavage such as occurs in Delta 1 by Kuzbanian (11) or by expression of transcripts encoding soluble forms of the ligand (20, 21) may be an important mechanism for down-regulating the activity of the Notch receptor through conventional endocytic pathways. Indeed, that the addition of antisense Jagged 1 to endothelial cells undergoing differentiation in an in vitro angiogenic assay potentiates the formation of chord-like structures in the presence of FGF-1 (12) ; the exaggeration of angiogenesis in the Jagged 1 null mouse results in early embryonic lethality (20) ; and implantation of lethally irradiated sJ1 (but not insert-less vector control) NIH 3T3 cell transfectants is able to induce the formation of vessels similar to that achieved with FGF-2 (21) support this premise.
The interactions between Src and Notch signaling pathways are not well described, with the exception of a report suggesting that Src activation may not play a role in the formation of tumors induced by overexpression of the constitutively active mutant of Notch 4, the int3 oncogene (49) . Indeed, like the caN1 and caN2 NIH 3T3 cell transfectants, the expression of the int3 oncogene (caN4) in NIH 3T3 cells did not alter Src signaling or induce the sJ1 phenotype (data not shown), suggesting that our results are consistent with those of Fitzgerald et al. (49) . Furthermore, the expression of either caN1 or caN2 did not yield the formation of a transformed phenotype in NIH 3T3 cells (data not shown), suggesting that Notch-mediated NIH 3T3 cell transformation may require the presence of another genetic element in addition to Src.
It is also possible that conventional Jagged 1-mediated Notch signaling may act as a suppressor for Src through interactions with other polypeptides genetically linked to Notch signaling pathways. Deltex, a cytosolic protein that has been shown to interact with the Notch ankyrin repeat domain, may be able to interact with and down-regulate Src through an SH3 domain ϫ 20) . B, the migratory ability of NIH 3T3 cells is impaired in transfectants expressing dnN1 and dnN2 (but not caN1 and caN2). Insert-less pMEXneo, caN1, caN2, dnN1, and dnN2 NIH 3T3 transfectants were analyzed using the response-to-injury model of cell migration as described (27) . Phase-contrast photomicrographs (magnification ϫ 10) are shown at the times indicated.
located within its structure (50) . Supt6H (EMB-5 in C. elegans), a protein implicated in regulating chromatin structure possibly through mediation of phosphoprotein interactions, interacts with the C. elegans Notch receptors LIN-12 and GLP-1 in a yeast two-hybrid system and has been genetically linked to some (but not all) of the cellular differentiation events mediated by Notch (51) . In contrast to Deltex, this polypeptide contains a SH2 domain that may facilitate interactions between tyrosine kinase and Notch signaling cascades (51) . In addition, the carboxyl terminus of Jagged 1 contains a PDZ motif (52) ; and thus, it is possible that like the ephrins and Eph receptors (53) , Jagged 1 may not only function as a ligand, but may itself be capable of signaling. If this were true, then interference of interactions between Jagged 1 and Notch by either soluble Jagged 1 or the soluble extracellular forms of the Notch receptors may also interfere with the ability of fulllength Jagged 1 to interact with the intracellular domains of receptor and non-receptor tyrosine kinase signaling pathways by contact with Notch-positive cells (52) . Indeed, the ephrins and Eph receptors may serve as a model for conventional Notch ligand-mediated signaling since our data suggest that like the soluble form of ephrin (54) , the soluble form of Jagged 1 acts as a repressor of the full-length Jagged 1 ligand.
As Notch receptor signaling is involved in the determination of cell fate and the ability to form chords is fundamental to the generation of the lumen-forming phenotype (55), our data also imply an unanticipated and divergent role for either Src or other members of the Src gene family in these processes and suggest that in a cell density-dependent manner, the migratory phenotype precedes the chord phenotype during the cellular differentiation pathway for lumen-containing structures. Because Eliceiri et al. (56) have recently shown that the attenuation of Src activity significantly represses angiogenesis in vivo, our data may also be relevant to the tubulogenic mechanism of angiogenesis. Because Src activity is known to be regulated by FGF in human endothelial cells (57), we anticipate that the signaling pathway regulated by sJ1 may ultimately be interactive with the FGF receptor signaling pathway. Indeed, studies in Drosophila with Branchless, the FGF homolog, and Breathless, the FGF receptor homolog, during tubulogenesis of the trachea have suggested their interaction with Notch signaling cells (58) . Since sJ1 expression results in the formation of a matrix-dependent chord-like phenotype and the regulation of the chord formation is a critical component of lumen formation mediated by endothelial and epithelial cells (43, 59, 60) , it is likely that inhibition of conventional Notch signaling resulting in the activation of a Src-dependent pathway by sJ1 may be involved in the regulation of cellular differentiation in a variety of diverse cell types in which chord formation is a component of the differentiation pathway.
